Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지
DOI QR코드

DOI QR Code

Utilization of Traditional Chinese Medicine for COVID-19 in China

중국의 COVID-19 대응을 위한 중의약 활용

  • Kim, Hanul (KM Policy Research Center, Korea Institute of Oriental Medicine) ;
  • Kim, Changwon (China Office, Korea Institute of Oriental Medicine) ;
  • Koo, Nampyong (China Office, Korea Institute of Oriental Medicine) ;
  • Yi, Junhyeok (KM Policy Research Center, Korea Institute of Oriental Medicine) ;
  • Yi, Eunhee (KM Policy Research Center, Korea Institute of Oriental Medicine) ;
  • Kim, Dongsu (KM Policy Research Center, Korea Institute of Oriental Medicine)
  • 김하늘 (한국한의학연구원 한의학정책연구센터) ;
  • 김창원 (한국한의학연구원 중국사무소) ;
  • 구남평 (한국한의학연구원 중국사무소) ;
  • 이준혁 (한국한의학연구원 한의학정책연구센터) ;
  • 이은희 (한국한의학연구원 한의학정책연구센터) ;
  • 김동수 (한국한의학연구원 한의학정책연구센터)
  • Received : 2020.08.04
  • Accepted : 2020.08.22
  • Published : 2020.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The objectives of this study were to investigate why and how China used traditional Chinese medicine as a response to COVID-19 and how its performance was achieved, and to explore ways to utilize traditional Korean medicine in Korea. Methods : We examined the information through government data and media articles. China's COVID-19 progress and policy response were reviewed and compared with Korea. Based on this, the characteristics of traditional Chinese medicine response in China were identified. Results : Based on legal basis, China makes the overall use of traditional Chinese medicines to respond to COVID-19. Traditional Chinese medicine has been applied to health insurance, the licensing regulations have been eased, and traditional Chinese medical specialists were dispatched. The medical care guidelines were developed and R&D were carried out. In addition, policies related to traditional Chinese medicine included policies for preventive treatment, the combination of Chinese and Western medicine, and telemedicine. Conclusions : Traditional Chinese medicine response to COVID-19 was included within the overall national quarantine policy, providing medical services for the mild stage. In addition, R&D was conducted to establish a basis for the utilization of traditional Chinese medicines. Traditional Korean medicine also needs to be prepared so that it can be used as a complement to the response of communicable diseases.

Keywords

References

  1. World Health Organization. Coronavirus disease 2019(COVID-19): situation report - 182. Available from: https://www.who.int/docs/default source/coronaviruse/situation-reports/20200720-covid-19-sitrep-182.pdf?sfvrsn=60aabc5c_2. Accessed on July 24, 2020.
  2. Korea Centers for Disease Control and Prevention. Regular briefing: COVID-19 domestic outbreak status(2020.05.28.). Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn=159064220445900.pdf&rs=/upload_comm/docu/0015/. Accessed on July 24, 2020.
  3. Ying Liu, Albert A Gayle, Annelies Wilder-Smith, Joacim Rocklov. The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine. 2020: Volume 27, Issue 2:taaa021.
  4. World Health Organization, Summary table of SARS cases by country, 1 November 2002-7 August 2003. Available from: https://www.who.int/csr/sars/country/2003_08_15/en/. Accessed on July 26, 2020.
  5. Jang I, Hsing L, Han C. An overview on severe acute respiratory syndrome(SARS) in WHO clinical reports. Korean J, Orient, Int. Med. 2005;26(2):440-452
  6. World Health Organization. SARS-Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine. Geneva. 2004.
  7. Korea Centers for Disease Control and Prevention. COVID-19 Response Guidelines (for local governments)-the 7th version. 2020.
  8. SBS News Press Release. [Daegu Connection] Fifth, self-isolation death...More than 2,000 people are waiting to be hospitalized. Available from: https://news.sbs.co.kr/news/endPage.do?news_id=N1005681219. Accessed on July 24, 2020.
  9. World Health Organization. Coronavirus disease 2019(COVID-19): situation report - 1. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4. Accessed on July 24, 2020.
  10. Association of Korean Medicine News. Operation of the Korean medicine TF to respond to COVID-19, Available from: http://www.akomnews.com/bbs/board.php?bo_table=news&wr_id=37958. Accessed on July 20, 2020.
  11. Korea Centers for Disease Control and Prevention. Regular briefing: COVID-19 domestic outbreak status(2020.02.24.). 2020. Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn=158997091504800.pdf&rs=/upload_comm/docu/0015/. Accessed on July 24, 2020.
  12. The Association of Korean Medicine. Announcement of the Korean medicine recommendations on treatment of COVID-19(the first version), Available from: http://www.akom.org/Home/AkomArticleNews/1098395?NewsType=7. Accessed on July 20, 2020.
  13. Association of Korean Medicine News. Announcement of the first version of Oriental Medicice Clinical Practice Guideline by the Korean Association of Traditional Pulmonary Medicine, Available from: http://akomnews.com/bbs/board.php?bo_table=news&wr_id=38324. Accessed on July 20, 2020.
  14. Maeil News. Korean medicine doctors came forward to overcome COVID-19 - free presciption after telemedicine, Available from: https://news.imaeil.com/Society/2020030812093281709. Accessed on July 24, 2020.
  15. State Council of the People's Republic of China. Announcement of the National Health Commission of the People's Republic of China, Available from: http://www.gov.cn/zhengce/zhengceku/2020-01/21/content_5471164.htm. Accessed on July 24, 2020.
  16. MedSci News. The gorvernment demands intervention in the treatment of COVID-19, Available from: https://m.medsci.cn/article/show_article.do?id=9290188231fb. Accessed on July 24, 2020.
  17. National Health Commission of the People's Republic of China. Guideline on diagnosis and treatment of COVID-19 (4th edition), Available from: http://www.nhc.gov.cn/yzygj/s7652m/202001/7450028ab6084101ae8110f0aaf81271.shtml. Accessed on July 24, 2020.
  18. State Council of the People's Republic of China. Notice about launch of online services for the epidemic prevention of the Hubei province, Available from: http://www.gov.cn/xinwen/2020-02/27/content_5483977.htm. Accessed on July 24, 2020.
  19. Korea Centers for Disease Control and Prevention. All-out response based on community response system, Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn=157966039194500.pdf&rs=/upload_comm/docu/0015/. Accessed on July 24, 2020.
  20. Ministry of Health and Welfare. Infectious Disease Crisis Alert Level Upgrades to "Orange (Level 3)", Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn=158020352565600.pdf&rs=/upload_comm/docu/0015/. Accessed on July 24, 2020.
  21. Korea Centers for Disease Control and Prevention. Approving emergency use of new COVID-19 diagnostic reagents, Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn=158079220350200.pdf&rs=/upload_comm/docu/0015/. Accessed on July 24, 2020.
  22. Yonhap News. Counseling and prescription by telephone due to mild cold symptoms are temporary allowed, Available from: https://www.yna.co.kr/view/AKR20200221083651017?input=1195m. Accessed on July 24, 2020.
  23. YTN. Briefing of the Central Disaster and Safety Countermeasures Headquarters on COVID-19 response, Available from: https://www.ytn.co.kr/_ln/0103_202002261122278900. Accessed on July 24, 2020.
  24. YTN. The government will take an active response so that people will not be treated unfairly, Available from: https://www.ytn.co.kr/_ln/0103_202002271102519073. Accessed on July 24, 2020.
  25. Association of Korean Medicine News. The Association of Korean Medicine publishes the guideline for telemedicine of Korean medicine, Available from: http://www.akomnews.com/bbs/board.php?bo_table=news&wr_id=38781. Accessed on July 24, 2020.
  26. National Health Commission of the People's Republic of China. Guideline on diagnosis and treatment of COVID-19 (1st edition), Available from:http://www.nhc.gov.cn/jkj/s3578/202002/34c1c337ef874fa58af58a1717005389.shtml. Accessed on July 24, 2020.
  27. Beijing News. Ministry of Science and Technology of the People's Republic of China: 16 emergency research projects were launched and some drugs were initially selected, Available from: https://www.sohu.com/a/370580329_114988. Accessed on July 24, 2020.
  28. National Healthcare Security Administration and the Ministry of Finance. Notice about good health coverage for COVID-19, Available from: http://www.gov.cn/xinwen/2020-01/30/content_5473177.htm. Accessed on July 24, 2020.
  29. Ministry of Science and Technology of the People's Republic of China. Notice about regulation of COVID-19 drug clinical research in medical institutions, Available from: http://www.most.gov.cn/tztg/202002/t20200225_151897.htm. Accessed on July 24, 2020.
  30. National Health Commission of the People's Republic of China. Nursing Standards for Medium and Critical Patients of COVID-19, Available from: http://www.nhc.gov.cn/yzygj/s7652m/202003/76bbb3c2b37c498588b2d1a11 ed6772e.shtml. Accessed on July 24, 2020.
  31. National Health Commission of the People's Republic of China. Plan of COVID-19 control and preventive(6th edition), Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202003/4856d5b0458141fa9f376853224d41d7.shtml. Accessed on July 24, 2020.
  32. National Administration of Traditional Chinese Medicine. Guidance on the Rehabilitation of Chinese medicine for COVID-19 recovery period, Available from: http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42768/xgzc42774/Document/1675757/1675757.htm. Accessed on Jyly 24, 2020.
  33. Xinhuanet. Obtain approval for clinical trials of 化湿败毒颗粒, Available from: http://www.xinhuanet.com/health/2020-03/22/c_1125750050.htm. Accessed on July 24, 2020.
  34. Law of the People's Republic of China on Traditional Chinese Medicine. Available from: http://fjs.satcm.gov.cn/zhengcewenjian/2018-03-24/2249.html. Accessed on July 20, 2020.
  35. Law of the People's Republic of China on Prevention and Treatment of Infectious Diseases. Available from: http://www.nhc.gov.cn/fzs/s3576/201808/58d2b24710c14c2f97ae6de5a8059b73.shtml. Accessed on July 20, 2020.
  36. State Council of the People's Republic of China. A press conference on February 20, 2020, Available from: http://www.nhc.gov.cn/xcs/s3574/202002/526411b8aa6143a487a6827aaa2f40ac.shtml. Accessed on July 24, 2020.
  37. Chinese Clinical Trial Registry, Available from: http://www.chictr.org.cn/index.aspx, Accessed on July 24, 2020.
  38. China Food and Drug Network News. Two cases of herbal medicine's hospital preparations for COVID-19 prevention and treatment have been approved in Sanxi Province, Available from: http://www.cqn.com.cn/cj/content/2020-02/17/content_8220883.htm. Accessed on July 24, 2020.
  39. Soju. Hospital preparation for COVID-19 of Pneumonia No. 1 and Qianli Pneumonia No. 1 have been approved in Hubei Province, Available from: https://www.sohu.com/a/375548592_260616. Accessed on July 24, 2020.
  40. Hubei Drug Administration. Hubei's first herbal medicine preparation for pneumonia caused by the new coronavirus infection, Available from: http://fda.hubei.gov.cn/fbjd/dtyw/202002/t20200219_2139257.shtml. Accessed on July 24, 2020.
  41. Yunnan Daily. Preparing for approval of seven medical institutions in Yunnan Province, Available from: http://yn.people.com.cn/n2/2020/0218/c378439-33804876.html. Accessed on July 24, 2020.
  42. National Administration of Traditional Chinese Medicine. Tujie Quwen Granules has passed an emergency approval and application for herbal medicine from Guangdong Medical Center, Available from: http://www.satcm. gov.cn/xinxifabu/gedidongtai/2020-02-06/12855.html. Accessed on July 24, 2020.
  43. China Broadcasting Network, Chengdu. Sichuan approves the use of three kinds of hospital preparations in 205 designated hospitals in the province, Available from: http://news.cnr.cn/native/city/20200212/t20200212_524971992.shtml. Accessed on July 24, 2020.
  44. Chinese Medicine Network. When the country is in trouble, the Chinese medicine doctors are responsible and they rush to the front, Available from: http://www.tmbos.com/index/article/view/id/14017.html. Accessed on July 24, 2020.
  45. Ministry of Science and Technology of the People's Republic of China. Local science and technology departments take active action to provide scientific and technical support for the prevention and control of infectious diseases, Available from: http://www.most.gov.cn/dfkj/dfkjyw/dfzxdt/202001/t20200130 _151268.htm. Accessed on July 24, 2020.
  46. National Administration of Traditional Chinese Medicine. Step-by-step progress has been made in the screening of effective herbal medicine prescriptions, and clinical observations in the experimental provinces shows that the total effectiveness of the treatment for clearing lung can be more than 90, Available from: http://bgs.satcm.gov.cn/gongzuodongtai/2020-02-06/12866.html. Accessed on July 24, 2020.
  47. Ministry of Science and Technology of the People's Republic of China.Tianjin University of Traditional Chinese Medicine actively carried out the research and clinical application of TCM to control COVID-19, Available from: http://www.most.gov.cn/dfkj/tj/zxdt/202002/t20200228_152017.htm. Accessed on July 24, 2020.
  48. National Intellectual Property Administration, PRC. Patent information on Chinese Medicine for the prevention and control of COVID-19, Available from: http://www.sipo.gov.cn/zscqgz/1146598.htm. Accessed on July 24, 2020.
  49. National Administration of Traditional Chinese Medicine. Available from: http://www.satcm.gov.cn/a/zcwj/.Accessed on 6 May, 2020.
  50. National Administration of Traditional Chinese Medicine. Notice about Chinese medicine prevention of COVID-19, Available from: http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-12/13036.html. Accessed on July 24, 2020.
  51. National Administration of Traditional Chinese Medicine. Notice about combination Chinese and Western medicine for COVID-19, Available from: http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-13/13053.html. Accessed on July 24, 2020.
  52. National Administration of Traditional Chinese Medicine. Notice of establishment of Chinese and Western medicine cooperative system in preventive treatment of infectious diseases, such as COVID-19, Available from: http://www.xinhuanet.com/health/2020-02/12/c_1125563760.htm. Accessed on July 24, 2020.
  53. National Administration of Traditional Chinese Medicine. Notice about strengthening information for support of Chinese medicines prevention for COVID-19, Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/09/content_5476446.htm. Accessed July on 24, 2020.
  54. South China Morning Post. China unveils targets for 2015: Li Keqiang's speech as it happened. South China Morning Post, Available from: https://www.scmp.com/news/china/article/1729846/live-li-keqiang-unveils-chinas-annual-work-report. Accessed on July 24, 2020.
  55. CCTV health. National Administration of Traditional Chinese Medicine: Chinese medicine accounted for 85.2% of Chinese national treatment, Available from: http://health.cnr.cn/jkgdxw/20200219/t20200219_524981526.shtml. Accessed on July 24, 2020.
  56. Korea Institute of Oriental Medicine. Chinese medicine trends related to COVID-19 in China. 2020.
  57. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020. Published online March 11, 2020:323(15):1499-1500. https://doi.org/10.1001/jama.2020.3633
  58. Greenhalgh T(b), Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020:368.
  59. Shen Ai-ming, Zhang Wei, Wu Zhuo, Wang Wen-long, Hua Jia-jia. TCM Theory analysis of Qing-Fei-Pai-Du-Tang in treating COVID-19. Liaoning Journal of Traditional Chinese Medicine. 2020.
  60. 路志正,路喜善."清肺排毒汤"彰显中医药抗疫疗效与自信. Journal of Traditional Chinese Medicine. 2020.
  61. Ang L, Lee HW, Choi JY, Zhang J, Lee MS. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integrative Medicine Research 2020;9(2). https://doi.org/10.1016/j.imr.2020.02.009
  62. National Health Commission of the People's Republic of China. Notice on the issuance of the new 7th version of the COVID-19 Diagnosis and Treatment Guideline. 2020.
  63. Gras G. Use of telemedicine in the management of infectious diseases. Medecine et maladies infectieuses. 2018:48:231-237. https://doi.org/10.1016/j.medmal.2018.01.005
  64. Burnham JP, Fritz SA, Yaeger LH, Colditz GA. Telemedicine Infectious Diseases Consultations and Clinical Outcomes: A Systematic Review. Open Forum Infect Dis. 2019:5;6(12):ofz517. https://doi.org/10.1093/ofid/ofz517
  65. Park SC, Park YC. Mental Health Care Measures in Response to the 2019 Novel Coronavirus Outbreak in Korea. Psychiatry Investigation. 2020:17(2):85-86. https://doi.org/10.30773/pi.2020.0058